Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria

Background: H1-antihistamines (H1AH) are the first-line treatment for chronic spontaneous urticaria (CSU), but 50% of patients have inadequate disease control at standard doses. Objective: To assess the comorbidity burden and healthcare resource utilization (HRU) associated with non-response to H1AH...

Full description

Bibliographic Details
Main Authors: Weily Soong, MD, Dhaval Patil, MS, Irina Pivneva, PhD, James Signorovitch, PhD, Michael A. Wells, PharmD, Maria-Magdalena Balp, MD, Merin Kuruvilla, MD
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123001035